Dan Schell/LinkedIn
Apr 4, 2025, 09:16
Dan Schell: How can we improve trial site Feasibility Assessments?
Dan Schell, Chief Editor and Clinical Leader at Life Science Connect, shared a post on LinkedIn:
“In 2021, American Society of Clinical Oncology (ASCO) made the following 3 recommendations to improve trial site feasibility assessments (FAs):
1. implement a streamlined and uniform FA process across trials and sponsors
2. minimize and standardize questions
3. leverage technology to centralize FAs, facilitate communications, and reduce redundancies.
Have we made enough improvements since then?”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 2, 2025, 18:07
Jun 2, 2025, 18:00
Jun 2, 2025, 17:43
Jun 2, 2025, 17:18
Jun 2, 2025, 17:06
Jun 2, 2025, 15:40
Jun 2, 2025, 15:37
Jun 2, 2025, 15:20